Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / January / Nanoparticle LEDs Advance DeepTissue Imaging
Technology and innovation Software and hardware Research and Innovations

Nanoparticle LEDs Advance Deep-Tissue Imaging

Hybrid organic–lanthanide nanoparticles produce electrically driven emission at diagnostic wavelengths

01/07/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Share

Clinical Scorecard: Nanoparticle LEDs Advance Deep-Tissue Imaging

At a Glance

CategoryDetail
ConditionDeep-Tissue Imaging
Key MechanismsElectrical activation of lanthanide-doped insulating nanoparticles for near-infrared light emission.
Target PopulationPatients requiring advanced imaging techniques.
Care SettingDiagnostic imaging and sensing systems.

Key Highlights

  • Lanthanide-doped nanoparticles produce stable NIR light for biomedical imaging.
  • Hybrid nanoparticles enable electrical activation without current passing through insulators.
  • Devices operate at low voltages (around 5 V) with narrow electroluminescence peaks.
  • Emission wavelengths can be tuned by changing the lanthanide dopant.
  • Potential for multiplexed optical detection in diagnostic applications.

Guideline-Based Recommendations

Diagnosis

  • Utilize stable NIR light sources for improved imaging quality.

Management

  • Consider hybrid nanoparticle designs for enhanced device performance.

Monitoring & Follow-up

  • Evaluate the efficiency of triplet energy transfer in devices.

Risks

  • Clinical applications are not yet established; further research needed.

Patient & Prescribing Data

Individuals undergoing advanced imaging procedures.

Potential for improved diagnostic accuracy with NIR light sources.

Clinical Best Practices

  • Incorporate electrically driven lanthanide emission in future imaging technologies.
  • Focus on nanoparticle and device design to enhance performance.

References

  • Nature Study on Nanoparticle LEDs

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.